(MedPage Today) — Vaccine maker Valneva will pull its chikungunya vaccine (Ixchiq) from the U.S. market after the FDA announced it would take further action to investigate the live-attenuated shot.
The FDA recently put the investigational new…
Source link : https://www.medpagetoday.com/infectiousdisease/vaccines/119506
Author :
Publish date : 2026-01-20 21:57:00
Copyright for syndicated content belongs to the linked Source.
